
Science communication, media relations, strategy and public affairs for European, international and national organisations, conferences and journals
Latest Press Releases
- ‘Pan-RAS molecular glue’ is a safe and effective treatment for lung and pancreatic cancers: results from AURORAS-1 clinical trialBarcelona, Spain: Results from the AURORAS-1 phase I clinical trial of an anti-cancer drug called ERAS-0015 have shown that it is safe and has caused tumours to shrink in hard-to-treat disease such as lung and pancreatic… Read more: ‘Pan-RAS molecular glue’ is a safe and effective treatment for lung and pancreatic cancers: results from AURORAS-1 clinical trial
- MYC inhibitor drug targets cancer cells directly and via the immune systemBarcelona, Spain: In a series of experiments, researchers have found that an experimental MYC inhibitor drug not only targets lung cancer cells directly but also makes cancer cells easier for the immune system to target and… Read more: MYC inhibitor drug targets cancer cells directly and via the immune system
- Metastatic pancreatic cancer responds well to initial treatment with combination of daraxonrasib and chemotherapyBarcelona, Spain: Daraxonrasib combined with chemotherapy caused substantial tumour shrinkage in patients with pancreatic cancer that had spread to other parts of the body, according to new results from a phase I/II clinical trial. In a… Read more: Metastatic pancreatic cancer responds well to initial treatment with combination of daraxonrasib and chemotherapy
- New drug IACS-6274 shows promise in phase I clinical trial treating patients with advanced ovarian cancerBarcelona, Spain: Patients with advanced, hard-to-treat ovarian cancer have responded well to treatment with a drug called IACS-6274 when combined with the targeted therapy bevacizumab and paclitaxel chemotherapy. Results from a phase I clinical trial in… Read more: New drug IACS-6274 shows promise in phase I clinical trial treating patients with advanced ovarian cancer